Endomag (acquired by Hologic Inc.)

Endomag is a breast cancer technology pioneer founded in 2007 to improve treatment for the two million women diagnosed with breast cancer each year.

Credit – Endomag

Endomag develops advanced technologies designed to prevent unnecessary surgery and improve patient surgical outcomes globally with advanced tools that are less invasive and more precise, such as its breast surgery localisation and lymphatic-tracing technologies.

Since the company’s inception, over 485,000 women have accessed its innovative treatments at over 1,350+ hospitals in more than 45 countries. Endomag, a King’s Award winner, recently agreed a takeover by Massachusetts-based Hologic Inc. for $310m. The company generated around $35m of revenue in 2023.

Endomag was founded in 2007 as a spin-out from the University College London and the University of Houston.

Career opportunities at Endomag

Briony Quested